Subscribe on Amazon Music / Audible, Apple Podcasts, Audacy, Deezer, Google Podcasts, iHeartRadio, Overcast, PlayerFM, Spotify, Stitcher, Vimeo, YouTube.
On April 21, 2023, the U.S. Supreme Court ruled to preserve access to the prescription abortion drug mifepristone. However, while the case continues in the U.S. Court of Appeals for the Fifth Circuit, the future of mifepristone—and the U.S. Food and Drug Administration’s authority to approve new drugs—will continue to be debated on appeal.
On this episode, Epstein Becker Green attorneys Erin Sutton, Delia Deschaine, and Avery Schumacher analyze the ongoing legal battle over mifepristone and discuss implications for industry stakeholders, including drug manufacturers, distributors, providers, and patients.
About the Diagnosing Health Care Podcast
The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.
Trouble listening to this podcast? Please contact us at thisweek@ebglaw.com and mention whether you were at home or working within a corporate network. We'd also love to hear your suggestions for future episode topics.
Subscribe to the Podcast
Never miss an episode! Subscribe to Diagnosing Health Care on your preferred platform – Amazon Music, Apple Podcasts, Audacy, Audible, Deezer, Goodpods, iHeartRadio, Overcast, Pandora, PlayerFM, Pocket Casts, Spotify, YouTube, YouTube Music.
.
Spread the Word
Would your colleagues, professional network, or friends benefit from Diagnosing Health Care? Please share the edition on LinkedIn, Facebook, X, YouTube, and YouTube Music, and your connections can subscribe for email notifications.
More Like This
Post-Dobbs: One Year Later
Employee and Health Benefits One Year After Dobbs- Managing Trade Secrets and Restrictive Covenants in Health Care M&A Deals
